Septerna to Present at Bank of America Securities Health Care Conference

Septerna (Nasdaq: SEPN) said CEO and co-founder Jeffrey Finer, M.D., Ph.D. will present at the Bank of America Securities Health Care Conference on May 12, 2026 at 5:00 p.m. PT in Las Vegas.

Rhea-AI Summary

Septerna (Nasdaq: SEPN) said CEO and co-founder Jeffrey Finer, M.D., Ph.D. will present at the Bank of America Securities Health Care Conference on May 12, 2026 at 5:00 p.m. PT in Las Vegas.

A live webcast will be available on the company investor site and archived for at least 30 days.

Argus May 5 session

-2.78% close to close Open Argus

Details

News Market Reaction – SEPN

On May 5, the day this news came out, SEPN closed 2.78% below the previous close.

Data tracked by StockTitan Argus for the May 5 session.

Key Figures

Conference date: May 12, 2026 Presentation time: 5:00 p.m. PT Webcast archive period: 30 days +5 more

Conference date

May 12, 2026

Bank of America Securities Health Care Conference presentation date

Presentation time

5:00 p.m. PT

Scheduled time for Septerna’s conference presentation in Las Vegas

Webcast archive period

30 days

Length of time the conference webcast will remain available

Current price

$24.82

Pre-news close relative to Bank of America conference announcement

1-day move

5.12%

Price change in the 24 hours before the news

52-week high

$32.63

Upper end of 52-week trading range before this news

52-week low

$6.415

Lower end of 52-week trading range before this news

Market cap

$1,060,239,490

Equity value prior to Bank of America conference announcement

Historical Context

5 past events · Latest: Apr 13

5 events

1. Apr 13

   Trial initiation

   24h Move

   +1.1%

   Began Phase 1 trial of SEP-479 with up to 150 healthy adults.

2. Mar 09

   Earnings and pipeline

   24h Move

   -3.6%

   Reported Q4 and 2025 results with strong cash and pipeline progress.

3. Feb 24

   Conference presentation

   24h Move

   +10.2%

   Announcement of CEO presentation at TD Cowen health care conference.

4. Feb 10

   Equity compensation

   24h Move

   -1.4%

   Inducement stock option grant to Chief Legal Officer under listing rule.

5. Feb 10

   Clinical data update

   24h Move

   +0.4%

   Planned presentation of Phase 1 SEP-631 data at AAAAI meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

g protein-coupled receptor, gpcr, webcast

3 terms

g protein-coupled receptor medical

"pioneering a new era of G protein-coupled receptor (GPCR) drug discovery"

A G protein-coupled receptor is a protein on a cell’s surface that acts like an antenna: it detects signals such as hormones, neurotransmitters or drugs outside the cell and passes that message inside to change cell behavior. Investors care because roughly a third of marketed medicines act on these receptors, so a company’s success in targeting or modulating a specific receptor can determine the value of drug candidates, regulatory risk, and future revenue potential.

gpcr medical

"pioneering a new era of G protein-coupled receptor (GPCR) drug discovery"

G protein-coupled receptors (GPCRs) are a large family of proteins on cell surfaces that act like locks sensing chemical signals — when the right key binds, they trigger internal cell responses. They matter to investors because GPCRs are the target of many marketed drugs and experimental therapies; success or failure in developing a GPCR-targeting drug can change a company’s revenue prospects, clinical progress, and licensing value, much like winning control of a widely used distribution channel.

webcast technical

"A live webcast of the presentation will be available in the investors section"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the Bank of America Securities Health Care Conference on Tuesday, May 12, 2026, at 5:00 p.m. PT in Las Vegas.

A live webcast of the presentation will be available in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation.

About Septerna
Septerna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform^® is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeline of novel oral small molecule drug candidates. Septerna is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. For more information, please visit www.septerna.com.

Investor Contact:
Renee Leck, THRUST
renee@thrustsc.com

Media Contact:
Carly Scaduto, THRUST
carly@thrustsc.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Septerna (SEPN) present at the Bank of America Health Care Conference?

Septerna will present on May 12, 2026 at 5:00 p.m. PT. According to Septerna, CEO Jeffrey Finer will deliver the presentation in Las Vegas; a live webcast is planned for investors who cannot attend in person.

How can investors watch Septerna's (SEPN) Bank of America conference presentation?

Investors can watch a live webcast on the company's investor website. According to Septerna, the webcast will be available at www.septerna.com and archived for at least 30 days after the presentation for later viewing.

Who from Septerna (SEPN) will present at the May 2026 conference?

Jeffrey Finer, M.D., Ph.D., CEO and co-founder of Septerna, will present. According to Septerna, Dr. Finer will discuss the company's clinical-stage GPCR drug discovery programs during the Bank of America Health Care Conference.

Will Septerna (SEPN) make new clinical disclosures at the Bank of America conference?

The announcement confirms a presentation but does not list specific new clinical data. According to Septerna, the CEO will present at the conference; investors should watch the webcast for any program updates or disclosures.

How long will Septerna's (SEPN) conference webcast remain available after May 12, 2026?

The webcast will be archived for at least 30 days following the presentation. According to Septerna, investors can access the archived webcast on the company investor website for that minimum period after the live event.